Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Revenue
Operating expenses:
General and administrative (including stock-based compensation (Note 7))	424,691	507,905
Depreciation	502	75,879
Research and development (including stock-based compensation (Note 7))	112,243	134,489
Total operating expenses	537,436	718,273
Loss from operations	(537,436)	(718,273)
Other expense:
Interest expense, net	92,764	114,756
Total other expense	92,764	114,756
Net loss	(630,200)	(833,029)
Net loss attributable to the noncontrolling interest	534	1,295
Net loss applicable to Bion's common stockholders	$ (629,666)	$ (831,734)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in dollars per share)	$ (0.03)	$ (0.04)
Basic and diluted (in shares)	23,544,122	22,289,077